Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome Inhibitors

ChemMedChem
James R HillAvril A B Robertson

Abstract

Insulin-secretory sulfonylureas are widely used, cost-effective treatments for type 2 diabetes (T2D). However, pancreatic β-cells are continually depleted as T2D progresses, thereby rendering the sulfonylurea drug class ineffective in controlling glycaemia. Dysregulation of the innate immune system via activation of the NLRP3 inflammasome, and the consequent production of interleukin-1β, has been linked to pancreatic β-cell death and multiple inflammatory complications of T2D disease. One proposed strategy for treating T2D is the use of sulfonylurea insulin secretagogues that are also NLRP3 inhibitors. We report the synthesis and biological evaluation of nine sulfonylureas that inhibit NLRP3 activation in murine bone-marrow- derived macrophages in a potent, dose-dependent manner. Six of these compounds inhibited NLRP3 at nanomolar concentrations and can also stimulate insulin secretion from a murine pancreatic cell line (MIN6). These novel compounds possess unprecedented dual modes of action, paving the way for a new generation of sulfonylureas that may be useful as therapeutic candidates and/or tool compounds in T2D and its associated inflammatory complications.

References

Dec 12, 2002·Diabetes·Peter ProksFrances Ashcroft
Jan 27, 2005·Drugs·Andrew J Krentz, Clifford J Bailey
Oct 14, 2005·Journal of Medicinal Chemistry·Richard Morphy, Zoran Rankovic
Nov 23, 2006·Nature Reviews. Drug Discovery·Simon Frantz
Dec 15, 2006·Nature·Steven E KahnKristina M Utzschneider
Apr 13, 2007·The New England Journal of Medicine·Claus M LarsenMarc Y Donath
Jun 21, 2007·Diabetes·Jan A EhsesMarc Y Donath
Aug 2, 2007·Accounts of Chemical Research·Bernard Meunier
Oct 7, 2009·The Journal of Cell Biology·Mohamed LamkanfiVishva M Dixit
Mar 23, 2010·Cell·Osamu Takeuchi, Shizuo Akira
Mar 23, 2010·Cell·Kate Schroder, Jurg Tschopp
Mar 23, 2010·Cell·Charles A Dinarello
Jun 19, 2010·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·M Fareed K SuriAdnan I Qureshi
Jan 11, 2011·Nature Medicine·Bolormaa VandanmagsarVishwa Deep Dixit
Jan 15, 2011·Nature Reviews. Immunology·Marc Y Donath, Steven E Shoelson
May 6, 2011·Science Translational Medicine·Seth L MastersLuke A J O'Neill
Jun 17, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Franz BauernfeindVeit Hornung
Mar 20, 2012·Cell·Frances M Ashcroft, Patrik Rorsman
Mar 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Kate SchroderMatthew J Sweet
Mar 8, 2013·Current Opinion in Microbiology·Kaiwen W Chen, Kate Schroder
May 25, 2013·Nature Reviews. Immunology·Eicke LatzAndrea Stutz
Sep 24, 2013·Immunity·Haitao WenJenny P-Y Ting
Dec 18, 2013·Journal of Cardiovascular Pharmacology·Carlo MarchettiAntonio Abbate
Feb 25, 2014·Current Diabetes Reports·Peter M Thulé, Guillermo Umpierrez
Mar 26, 2014·Journal of Cardiovascular Pharmacology·Michael J Lipinski, Juan C Frias
May 7, 2014·Diabetes Research and Clinical Practice·Nathalie EsserNicolas Paquot
May 21, 2014·Annals of the New York Academy of Sciences·Fayyaz S SutterwalaSuzanne L Cassel
May 24, 2014·Nature Reviews. Drug Discovery·Marc Y Donath
Jun 20, 2014·Journal of Medicinal Chemistry·Andrew AnighoroGiulio Rastelli
Jan 30, 2015·Microbial Biotechnology·Wei E HuangJian Xu
May 20, 2015·World Journal of Diabetes·Iqra HameedBashir A Ganai
Jun 30, 2015·Nature Medicine·Haitao GuoJenny P-Y Ting
Oct 1, 2015·Journal of Medicinal Chemistry·Alex G BaldwinSally Freeman
Jan 23, 2016·Journal of Diabetes and Its Complications·Jay J SalazarTimothy J Koh
Aug 16, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael J PrimianoJ Perry Hall

❮ Previous
Next ❯

Citations

Dec 17, 2017·Immunological Reviews·Mark M Hughes, Luke A J O'Neill
Nov 24, 2018·Diabetes/metabolism Research and Reviews·Evangelia KalaitzoglouKathryn M Thrailkill
Nov 5, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Md Ezazul HaqueDong-Kug Choi
Nov 2, 2018·Science Translational Medicine·Richard GordonTrent M Woodruff
Jul 22, 2018·Nature Reviews. Drug Discovery·Matthew S J ManganEicke Latz
Apr 25, 2019·EMBO Molecular Medicine·Sofie VoetGeert van Loo
Jul 25, 2019·Journal of Cardiovascular Pharmacology·Carlo Marchetti
Oct 8, 2020·Ocular Immunology and Inflammation·Karanvir S Raman, Joanne A Matsubara
Nov 9, 2019·European Journal of Medicinal Chemistry·Xiangna ZhangJingde Wu
May 19, 2021·ACS Chemical Biology·Cassandra R KennedyEdward W Tate
May 18, 2021·Frontiers in Chemistry·Tim KeulerMichael Gütschow
Jun 15, 2021·Frontiers in Cardiovascular Medicine·Hayder M Al-KuraishyGaber El-Saber Batiha
Aug 28, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Biswadeep DasAkash Agnihotri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here